SS
CINC

Steve Schonfeld’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Steve Schonfeld’s Portfolio CINC Stock Details CINC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-250,556
Closed -$3.08M – 2954
2022
Q4 		$3.08M Buy
+250,556
New +$5.97M 0.03% 657

Steve Schonfeld's CINC Position: Q1 2023 in Review

Steve Schonfeld sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 250,556 shares — an estimated $3.08M sold.

Steve Schonfeld first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $3.08M in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

  • Steve Schonfeld reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Steve Schonfeld sold 250,556 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $3.08M.
  • Steve Schonfeld first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Steve Schonfeld's CinCor Pharma, Inc. Common Stock position peaked at $3.08M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2023, filed 15 May 2023.